FABP5 and fatty liver disease: Similarly, the exacerbation of hepatic steatosis, inflammation, and fibrosis induced by hepatocyte‐specific overexpression of asprosin in HFHFHC mice was also rescued by hepatocyte‐specific knockdown of FABP5 (Figure 7g,h).